Acumen Pharmaceuticals (ABOS) Return on Assets (2021 - 2026)

Acumen Pharmaceuticals (ABOS) has 6 years of Return on Assets data on file, last reported at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.01%, down 1.0% from the prior year.
• Return on Assets climbed to 0.01% in Q1 2026, from 0.01% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q4 2023 to a low of 0.01% in Q4 2025.
• A 5-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Assets.
• Across the five-year window, Return on Assets changed 0 bps in 2022 and fell 1 bps in 2025, its largest moves.
• Tracing ABOS's Return on Assets over 5 years: stood at 0.0% in 2022, then surged by 64 bps to 0.0% in 2023, then tumbled by 131 bps to 0.0% in 2024, then sank by 124 bps to 0.01% in 2025, then advanced by 3 bps to 0.01% in 2026.
• Business Quant data shows ABOS's Return on Assets at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.